BCM
APGN

Basso Capital Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Basso Capital Management’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,667
Closed -$129K – 537
2022
Q2 		$129K Sell
12,667
-144,573
-92% -$1.46M 0.01% 417
2022
Q1 		$1.58M Sell
157,240
-123,880
-44% -$1.24M 0.15% 238
2021
Q4 		$2.81M Hold
281,120
– – 0.31% 117
2021
Q3 		$2.8M Buy
281,120
+148,106
+111% +$1.46M 0.33% 116
2021
Q2 		$1.32M Buy
133,014
+92,412
+228% +$915K 0.17% 204
2021
Q1 		$399K Buy
+40,602
New +$406K 0.06% 230

Other funds holding APGN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Basso Capital Management's APGN Position: Q3 2022 in Review

Basso Capital Management sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 12,667 shares — an estimated $129K sold.

Basso Capital Management first reported a position in APGN in Q1 2021 and held it in 6 quarters. The position peaked at $2.81M in Q4 2021. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

  • Basso Capital Management reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Basso Capital Management sold 12,667 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $129K.
  • Basso Capital Management first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Basso Capital Management's Apexigen, Inc. Common Stock position peaked at $2.81M in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Basso Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.